Who owns Cogent Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of COGT from SEC Form 13F filings across 317 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 317 institutions disclosed 200.3M shares of Cogent Biosciences, Inc. worth $6.41B — about 115.7% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
317
13F holders
$6.41B
value, 2026 filers
115.7%
of shares outstanding (200.3M sh)
54
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of COGT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 26.9M | $859.8M | 0.0% | 15.5% | +4.6% |
| 2 | BlackRock, Inc. | 17.2M | $551.7M | 0.0% | 10% | -0.7% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.1M | $260.4M | 0.0% | 4.7% | +0.7% |
| 4 | STATE STREET CORP | 7.8M | $248.8M | 0.0% | 4.5% | +11.6% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 7.4M | $238.5M | 0.0% | 4.3% | +0.5% |
| 6 | Janus Henderson Group Ltd.NEW | 7.4M | $238.0M | 0.1% | 4.3% | new |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. | 6.0M | $190.7M | 3.0% | 3.4% | +19.0% |
| 8 | Fairmount Funds Management LLC | 5.5M | $176.2M | 11.1% | 3.2% | 0.0% |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | 4.7M | $149.8M | 0.0% | 2.7% | +7.7% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 4.5M | $143.4M | 0.0% | 2.6% | -0.7% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.1M | $132.4M | 0.0% | 2.4% | -11.1% |
| 12 | Kynam Capital Management, LP | 3.8M | $121.4M | 6.7% | 2.2% | +3.4% |
| 13 | Polar Capital Holdings Plc | 3.5M | $111.1M | 0.3% | 2% | +7.3% |
| 14 | Invesco Ltd. | 3.2M | $103.2M | 0.0% | 1.9% | +23.6% |
| 15 | Pictet Asset Management Holding SA | 2.8M | $91.0M | 0.1% | 1.6% | +18.8% |
| 16 | TCG Crossover Management, LLC | 2.5M | $80.1M | 2.3% | 1.4% | -48.5% |
| 17 | Deep Track Capital, LP | 2.5M | $80.0M | 1.3% | 1.4% | +25.0% |
| 18 | ALLIANCEBERNSTEIN L.P. | 2.4M | $78.0M | 0.0% | 1.4% | +325.6% |
| 19 | GOLDMAN SACHS GROUP INC | 2.4M | $76.1M | 0.0% | 1.4% | +3.9% |
| 20 | Octagon Capital Advisors LP | 2.4M | $75.2M | 10.0% | 1.4% | 0.0% |
| 21 | RTW INVESTMENTS, LP | 2.3M | $73.9M | 0.7% | 1.3% | 0.0% |
| 22 | Driehaus Capital Management LLCNEW | 2.1M | $65.7M | 0.5% | 1.2% | new |
| 23 | ORBIMED ADVISORS LLC | 2.0M | $64.2M | 1.2% | 1.2% | +19.2% |
| 24 | Woodline Partners LP | 2.0M | $64.1M | 0.2% | 1.2% | -23.2% |
| 25 | Candriam S.C.A. | 2.0M | $63.0M | 0.3% | 1.1% | -6.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.